BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND uPA AND Diagnosis
7 results:

  • 1. Prognostic evaluation of oral squamous cell carcinoma based on pleiotrophin, urokinase plasminogen activator, and glycoprotein nonmetastatic melanoma protein B expression.
    Ma Y; Liu Y; Meng H
    Medicine (Baltimore); 2023 Nov; 102(45):e35634. PubMed ID: 37960806
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Salivary KLK5 and upa are potential biomarkers for malignant transformation of OLK and OLP.
    Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
    Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
    Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
    Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
    Ulisse S; Baldini E; Sorrenti S; Barollo S; Gnessi L; Catania A; Pellizzo MR; Nardi F; Mian C; De Antoni E; D'Armiento M; Frati L
    J Clin Endocrinol Metab; 2011 Feb; 96(2):504-8. PubMed ID: 21106716
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Urinary-type plasminogen activator (upa) and its receptor (upaR) in squamous cell carcinoma of the oral cavity.
    Shi Z; Stack MS
    Biochem J; 2007 Oct; 407(2):153-9. PubMed ID: 17880283
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction.
    Lagarde SM; ten Kate FJ; Richel DJ; Offerhaus GJ; van Lanschot JJ
    Ann Surg Oncol; 2007 Feb; 14(2):977-91. PubMed ID: 17122988
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Urokinase-type plasminogen activator (upa) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients.
    Strojan P; Budihna M; Smid L; Vrhovec I; Skrk J
    Eur J Cancer; 1998 Jul; 34(8):1193-7. PubMed ID: 9849478
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.